Analysts See $0.00 EPS for VEON Ltd (ADR) (VEON); Shorts at PRESSURE BIOSCIENC (PBIO) Raised By 591.67%

Analysts expect VEON Ltd (ADR) (NASDAQ:VEON) to report $0.00 EPS on May, 11 before the open. The stock increased 1.96% or $0.08 during the last trading session, reaching $4.17. About shares traded. VEON Ltd (ADR) (NASDAQ:VEON) has risen 18.80% since October 3, 2016 and is uptrending. It has outperformed by 7.90% the S&P500.

PRESSURE BIOSCIENC (OTCMKTS:PBIO) had an increase of 591.67% in short interest. PBIO’s SI was 8,300 shares in May as released by FINRA. Its up 591.67% from 1,200 shares previously. The stock decreased 6.86% or $0.02 on May 9, reaching $0.27. About 82,319 shares traded or 10.38% up from the average. Pressure Biosciences Inc (OTCMKTS:PBIO) has declined 32.50% since October 3, 2016 and is downtrending. It has underperformed by 43.41% the S&P500.

VEON Ltd., formerly VimpelCom Ltd., is a well-known provider of communications services. The company has market cap of $14.82 billion. The Firm operates as personal internet platform. It currently has negative earnings. It integrates powerful data analytics and artificial intelligence, with a fresh take on messaging capabilities.

Pressure BioSciences, Inc. is focused on solving the problems inherent in biological sample preparation. The company has market cap of $8.81 million. The Firm has developed and patented a technology platform that can control the sample preparation process. It currently has negative earnings. This process, called pressure cycling technology , uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels, such as approximately 35,000 pounds per square inch (psi) or greater to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources.